Related Experiment Videos

[Hepatic mitochondrial fatty acid oxidation disorders]

¹Department of Biochemical Genetics, Tohoku University School of Medicine.

Ryoikibetsu Shokogun Shirizu

|January 1, 1995

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Effect of prior anti-EGFR therapy and baseline ctDNA profiling on the efficacy of pertuzumab plus trastuzumab in HER2-amplified metastatic colorectal cancer: an integrated analysis of TRIUMPH/MyPathway.

ESMO open·2026

Impact of claudin 18.2 expression on the efficacy of trastuzumab deruxtecan in patients with HER2-positive gastric or gastroesophageal junction cancer.

ESMO gastrointestinal oncology·2026

Temporal dynamics of CLDN18.2 expression following zolbetuximab treatment in advanced gastric cancer.

ESMO gastrointestinal oncology·2026

BAYONET trial: staged combination with encorafenib, binimetinib, plus cetuximab following encorafenib plus cetuximab for <i>BRAF</i> V600E-mutant metastatic colorectal cancer.

ESMO gastrointestinal oncology·2026

Clinical implementation of simultaneous multiple biomarkers testing for metastatic or recurrent gastroesophageal adenocarcinoma: a single-institutional experience.

ESMO gastrointestinal oncology·2026

Characterization of early-onset gastritis during zolbetuximab-containing chemotherapy in CLDN18.2-positive gastric cancer.

ESMO open·2025

See all related articles